Eluxadoline for Irritable Bowel Syndrome with Diarrhea

The New England Journal of Medicine
Anthony LemboP S Covington

Abstract

Background Effective and safe treatments are needed for patients who have irritable bowel syndrome (IBS) with diarrhea. We conducted two phase 3 trials to assess the efficacy and safety of eluxadoline, a new oral agent with mixed opioid effects (μ- and κ-opioid receptor agonist and δ-opioid receptor antagonist), in patients with IBS with diarrhea. Methods We randomly assigned 2427 adults who had IBS with diarrhea to eluxadoline (at a dose of 75 mg or 100 mg) or placebo twice daily for 26 weeks (IBS-3002 trial) or 52 weeks (IBS-3001 trial). The primary end point was the proportion of patients who had a composite response of decrease in abdominal pain and improvement in stool consistency on the same day for at least 50% of the days from weeks 1 through 12 and from weeks 1 through 26. Results For weeks 1 through 12, more patients in the eluxadoline groups (75 mg and 100 mg) than in the placebo group reached the primary end point (IBS-3001 trial, 23.9% with the 75-mg dose and 25.1% with the 100-mg dose vs. 17.1% with placebo; P=0.01 and P=0.004, respectively; IBS-3002 trial, 28.9% and 29.6%, respectively, vs. 16.2%; P<0.001 for both comparisons). For weeks 1 through 26, the corresponding rates in IBS-3001 were 23.4% and 29.3% versu...Continue Reading

References

Aug 1, 1979·Gastroenterologia Japonica·T KagayaK Oyama
Jul 1, 1989·Journal of Gastroenterology and Hepatology·I C Roberts-ThomsonJ Toouli
Oct 1, 1988·Gut·J F HelmR C Arndorfer
Jan 1, 1987·Scandinavian Journal of Gastroenterology. Supplement·B LavöA L Nielsen
Jan 1, 1987·The American Journal of Drug and Alcohol Abuse·L HandelsmanP D Kanof
Mar 1, 1984·Digestive Diseases and Sciences·P A CannD Barends
May 1, 1996·Scandinavian Journal of Gastroenterology·P S EfskindM H Vatn
Nov 30, 2000·The American Journal of Gastroenterology·P HastierJ P Delmont
Sep 25, 2001·The American Journal of Gastroenterology·T LemboUNKNOWN Lotronex Investigator Team
Aug 4, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anthony J LemboEric G Carter
Aug 10, 2004·Journal of Managed Care Pharmacy : JMCP·Darrell Hulisz
Jan 19, 2005·The American Journal of Gastroenterology·Lin ChangEmeran A Mayer
Aug 6, 2005·Journal of Clinical Gastroenterology·Chirag D Trivedi, C S Pitchumoni
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
Mar 31, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Nison BadalovScott Tenner
Jun 27, 2007·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Stephen J Pandol, Michael Raraty
Feb 5, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Viola AndresenMichael Camilleri
Apr 7, 2009·Regulatory Peptides·Peter Holzer
May 29, 2009·British Journal of Anaesthesia·N DietisD G Lambert
Jan 7, 2011·The New England Journal of Medicine·Mark PimentelUNKNOWN TARGET Study Group
Aug 14, 2012·Gastroenterology·Anne F PeeryNicholas J Shaheen
Oct 27, 2012·Gut·Peter A BanksUNKNOWN Acute Pancreatitis Classification Working Group
Apr 16, 2013·Gastroenterology·Leonard S DovePaul S Covington
Aug 6, 2014·The American Journal of Gastroenterology·Alexander C FordEamonn M M Quigley

❮ Previous
Next ❯

Citations

May 10, 2016·Nature Reviews. Disease Primers·Paul EnckRobin C Spiller
Apr 27, 2019·Current Gastroenterology Reports·Akhil MunjalBrooks Cash
Jul 25, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Giovanni DothelCatia Sternini
Sep 24, 2018·Gut·Alexander Charles Ford, Peter R Gibson
Dec 14, 2019·Laboratory Medicine·Iván González, Stephen Roper
Dec 5, 2019·Clinical and Translational Gastroenterology·Judy NeeAnthony J Lembo
Jan 28, 2020·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Anthony J LemboDavid A Andrae
Dec 11, 2019·Minerva gastroenterologica e dietologica·Imke MasuyJan Tack
Feb 4, 2016·Nature Reviews. Gastroenterology & Hepatology·Iain Dickson
Oct 12, 2016·The American Journal of Gastroenterology·Shanti L EswaranKenya Jackson
Mar 28, 2018·Current Gastroenterology Reports·Arnold Wald
Jul 7, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Lingping ZhuZhiqun Shu
Aug 10, 2018·Internal Medicine Journal·Chamara BasnayakeAlexander J Thompson
Oct 24, 2018·Journal of Neurogastroenterology and Motility·Young Sun Kim, Nayoung Kim
Sep 30, 2018·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jessica L AbelDavid A Andrae
Dec 15, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Agata SzymaszkiewiczMarta Zielinska
Dec 28, 2018·Alimentary Pharmacology & Therapeutics·L HarinsteinA Brinker
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Emidio ScarpelliniAntonio Gasbarrini
Feb 25, 2017·Gut·Michael Camilleri, Guy Boeckxstaens
May 4, 2017·MMW Fortschritte der Medizin·Matthias Wettstein
Oct 18, 2016·European Journal of Pain : EJP·D ReissC Gavériaux-Ruff
Sep 22, 2017·Therapeutic Advances in Gastroenterology·Sherry Levio, Brooks D Cash
Aug 16, 2017·Drug and Therapeutics Bulletin
Apr 12, 2017·Current Gastroenterology Reports·Lawrence R Schiller
Mar 27, 2018·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D M BrennerW D Chey
Nov 7, 2018·Current Gastroenterology Reports·Hans Törnblom, Douglas A Drossman
Oct 14, 2018·The American Journal of Gastroenterology·Afrin Kamal, Mark Pimentel
Sep 1, 2018·Inflammatory Bowel Diseases·Afrin KamalBret Lashner
Sep 24, 2020·Gastroenterology Research and Practice·Mark A FlemingDaniel E Levin
Feb 10, 2016·The American Journal of Gastroenterology·William D Chey
Feb 26, 2016·Expert Review of Gastroenterology & Hepatology·Maura Corsetti, Peter Whorwell
Jul 21, 2016·Journal of the American Association of Nurse Practitioners·Brian E Lacy, Julie C Moreau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Reginald V FantP S Covington
The American Journal of Gastroenterology
Brooks D CashP S Covington
The American Journal of Gastroenterology
Brian E LacyP S Covington
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society
Darren M BrennerW D Chey
© 2022 Meta ULC. All rights reserved